Skip to Main Content

Paper Details

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).
Oncologist
12
2020
Author NameAffiliation
Jeff A SloanMayo Clinic
Robert B DiasioMayo Clinic
Al B BensonNorthwestern University
  • 1 - 3

Datasets

Release 1.2